Long Term Survivor with Erlotinib in Metastatic Lung Cancer-Squamous Cell Carcinoma Subtype

Currently, data that supports the clinical benefit of agents targeting the epidermal growth factor receptor (EGFR) in the therapy of squamous cell carcinoma (SCC) histologic version of the lung cancer (LC) is insufficient. In the following report we present the case of a patient treated with erlotin...

Descripción completa

Detalles Bibliográficos
Autores principales: VATU, BOGDAN IONEL, CRISTIAN, TUŢĂ, ARTENE, STEFAN, STIUCA, ADELINA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716763/
https://www.ncbi.nlm.nih.gov/pubmed/33304633
http://dx.doi.org/10.12865/CHSJ.46.03.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716763/
https://www.ncbi.nlm.nih.gov/pubmed/33304633
http://dx.doi.org/10.12865/CHSJ.46.03.13

Ejemplares similares